ten23 health announced today that it obtained GMP certifications for pharmaceutical manufacturing in a duo of Swiss facilities. The company secured licenses to manufacture and test advanced therapy medicinal product (ATMP) in its Basel and Visp, Switzerland, plants. It said this marks a significant milestone in the planned strategic expansion for the global contract development…
BD partners with ten23 health on prefilled syringe manufacturing
BD (NYSE:BDX) announced today that it entered into a collaboration with ten23 health to develop a new way to track prefillable syringes (PFS). ten23 health, a Swiss CDMO, offers drug development, filling and device assembly expertise to contribute to the product offering. It recently entered into a production collaboration with on-body drug delivery device maker…